Medistep Healthcare IPO Subscription Status
Medistep Healthcare IPO received bids for 1,33,41,54,000 shares against 35,52,000 offered, an overall subscription of 375.61x at the close of bidding (12 Aug 2025). Retail leads at 461.95x, while QIB (0.00x) portion is undersubscribed.
Last updated · day 3 figures
- Retail
- 461.95x
- NII
- 275.37x
- QIB
- 0.00x
- Total
- 375.61x
Where the demand is
Medistep Healthcare IPO subscription by category
| Category | Shares offered | Shares bid | Amount bid | Subscription |
|---|---|---|---|---|
| QIB | 0 | 2,46,63,000 | ₹106.05 Cr | 0.00x |
| NII | 17,76,000 | 48,90,63,000 | ₹2,102.97 Cr | 275.37x |
| Retail | 17,76,000 | 82,04,28,000 | ₹3,527.84 Cr | 461.95x |
| Total | 35,52,000 | 1,33,41,54,000 | ₹5,736.86 Cr | 375.61x |
* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.
Application-wise breakup and allotment chances
| Category | Lots reserved | Applications | Applied | Chance per application |
|---|---|---|---|---|
| QIB | — | 37 | — | — |
| NII | — | 29,373 | — | — |
| Retail | — | 1,36,738 | — | — |
"All valid" means applications are fewer than the lots reserved, so every valid application should get at least one lot. When applications exceed lots, allottees are picked by computerised lottery and "1 in X" is the rough chance for one application. The real chance is usually a little better: bids below the cut-off price and invalid applications are removed before the lottery.
Medistep Healthcare IPO subscription day-wise
| Category | Day 3 |
|---|---|
| QIB | 0.00x |
| NII | 275.37x |
| Retail | 461.95x |
| Total | 375.61x |
| Total added | 375.61x |
Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.
Medistep Healthcare IPO reservation
| Category | Shares | Share of issue |
|---|---|---|
| Non-Institutional Investors | 17,76,000 | 50.00% |
| Retail Individual Investors | 17,76,000 | 50.00% |
| Public issue | 35,52,000 | 100% |
Allotment Chances Note
These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:
- Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
- Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
- Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.
Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.
Medistep Healthcare IPO subscription: FAQs
- What is the overall subscription of Medistep Healthcare IPO?
- Medistep Healthcare IPO is subscribed 375.61x overall as of day 3 (12 August 2025), with bids for 1,33,41,54,000 shares against 35,52,000 offered.
- What is the retail subscription of Medistep Healthcare IPO?
- The retail portion is subscribed 461.95x as of day 3 (12 August 2025).
- What is the QIB and NII subscription of Medistep Healthcare IPO?
- QIBs have subscribed 0.00x of their portion, and NIIs 275.37x as of day 3 (12 August 2025).
- How can I check Medistep Healthcare IPO subscription status live?
- This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
- How do I apply for Medistep Healthcare IPO?
- Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 12 August 2025.
Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.